Improving Alignment In Drug Development

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/90/22/1a/90221aad-9b3d-59dc-87ee-1e482d6044f3/mza_8352392173652811543.jpg/600x600bb.jpg

P4A Let's Talk Rare: The Life Science Podcast

Partners4Access

104 episodes

1 week ago

Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com

Science

RSS

All content for P4A Let's Talk Rare: The Life Science Podcast is the property of Partners4Access and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/654908/654908-1695651065580-d95ad5cf85462.jpg

Improving Alignment In Drug Development

P4A Let's Talk Rare: The Life Science Podcast

36 minutes 35 seconds

6 months ago

Improving Alignment In Drug Development

In the latest episode of Let's Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases.

They are joined by the brilliant Rob Freishtat, president of Uncommon Cures. Rob brings unique insights on who the key stakeholder are in developing drugs and the many ways that we can bring them together in order to improve and enhance the delivery of much-needed therapies.